Preliminary findings from PREVAIL III, a study of Ebola virus disease (EVD) survivors being conducted in Liberia, indicate that both Ebola survivors and their close contacts have a high burden of illness. However, the prevalence of eye, musculoskeletal, and neurological complications was greater among the individuals who survived EVD.
Initial results from PREVAIL III were presented this evening at the Conference on Retroviruses and Opportunistic Infections in Boston by study co-principal investigator Mosoka Fallah, PhD, MPH, with the Liberian Ministry of Health. PREVAIL III began in June 2015 and is co-sponsored by the Liberian Ministry of Health and the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH. The trial is expected to enroll 7,500 people throughout Liberia, including 1,500 EVD survivors of any age and up to 6,000 of their close contacts, with participants followed for up to five years and study visits every six months.
Through February 15, 2016, the study had enrolled 1,049 EVD survivors and 1,034 close contacts with average ages of 30 and 26 years, respectively. On average, survivors enrolled in the study about one year after experiencing EVD symptoms. Investigators found that as self-reported by survivors, 60 percent experienced eye problems, 53 percent had musculoskeletal problems and 68 percent had neurological difficulties. Close contacts, who were potentially exposed to the Ebola virus but did not become infected, reported similar problems, albeit less frequently: 59 percent reported vision problems, 28 percent had musculoskeletal issues, and 48 percent had neurological issues.
Ninety-seven male survivors provided one or more semen samples for analysis. Overall, 38 percent of these men had Ebola detected in their semen at least once. In one-third of the 69 men who were tested more than once, virus detection in semen was intermittent (negative results then positive, or vice versa). The maximum amount of time between EVD symptoms and detection of Ebola in a semen sample was 18 months. Most survivors reported being sexually active. In a subset of 126 close contacts who reported sexual activity with a survivor, only four percent reported regular condom use, raising concerns about the potential for sexual transmission of EVD. However, so far, no cases of sexual transmission of Ebola have been detected in the PREVAIL III study.
Source: NIH/National Institute of Allergy and Infectious Diseases
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.